Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN)

51 filings reported holding TERN - Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q2 2022.
Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14,707,603 shares of 87,692,308 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3,791,204 shares), Vivo Capital, LLC (2,675,133 shares), RA CAPITAL MANAGEMENT, L.P. (1,261,435 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1,238,800 shares), Antara Capital LP (874,600 shares), Decheng Capital Management III (Cayman), LLC (714,285 shares), Ikarian Capital, LLC (700,000 shares), Point72 Asset Management, L.P. (500,000 shares), Affinity Asset Advisors, LLC (401,268 shares), and VANGUARD GROUP INC (367,529 shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.